Risk factor
Low price volatility
Profitability factor
Very strong margins and returns
About
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic models and 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, of fair va
Target Price
The average target price of MOVE.SW is 171 and suggests 6% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation
Buy
Sell